Avibactam/ceftazidimeAcquired resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1972卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45454-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：73 / 73

相关论文

共 50 条

[41] Avibactam/ceftazidimeEmergence of resistance: 2 case reports
Reactions Weekly, 2018, 1698 (1) : 58 - 58
[42] Avibactam/ceftazidimeClostridium difficile infection: case report
Reactions Weekly, 2017, 1645 (1) : 51 - 51
[43] Avibactam/ceftazidime/fluconazoleLack of efficacy: case report
Reactions Weekly, 2023, 1972 (1) : 74 - 74
[44] Amikacin/avibactam/ceftazidimeTreatment failure: case report
Reactions Weekly, 2020, 1796 (1) : 23 - 23
[45] Avibactam/ceftazidime/cotrimoxazole/dalbavancinThrombocytopenia: case report
Reactions Weekly, 2025, 2054 (1) : 79 - 79
[46] Avibactam/ceftazidimeAcute hives on toe: case report
Reactions Weekly, 2019, 1744 (1) : 61 - 61
[47] Avibactam/ceftazidime/MetronidazoleLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 80 - 80
[48] Avibactam/ceftazidime/meropenemLack of efficacy: case report
Reactions Weekly, 2023, 1939 (1) : 96 - 96
[49] Avibactam/ceftazidime/meropenemDevelopment of resistance in KPC-producing Klebsiella pneumoniae infection: case report
Reactions Weekly, 2018, 1709 (1) : 42 - 42
[50] AntibioticsNephrotoxicity and development of avibactam/ceftazidime and meropenem resistance in the emerging Klebsiella pneumoniae clone: case report
Reactions Weekly, 2018, 1696 (1) : 35 - 35

← 1 2 3 4 5 →